Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Jan 01, 2023 09:21AM
|
Re: can it be done legally
|
1
|
Resverlogix Corp.
|
Dec 14, 2022 10:11PM
|
Re: RVV insider purchases
|
2
|
Resverlogix Corp.
|
Dec 12, 2022 10:20PM
|
Re: RVV insider purchases
|
4
|
Resverlogix Corp.
|
Dec 12, 2022 07:06PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 06:49PM
|
Re: find it interesting that RVXCF.....
|
5
|
Resverlogix Corp.
|
Nov 10, 2022 05:54PM
|
RVX…The Hawthorne Effect
|
4
|
Resverlogix Corp.
|
Oct 01, 2022 11:18AM
|
Re: Latest on COVID-19
|
6
|
Resverlogix Corp.
|
Sep 28, 2022 12:49PM
|
Re: No news, did you expect a change
|
9
|
Resverlogix Corp.
|
Sep 21, 2022 03:27PM
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 30, 2022 03:30PM
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
5
|
Resverlogix Corp.
|
Aug 30, 2022 08:42AM
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
4
|
Resverlogix Corp.
|
Aug 23, 2022 10:54PM
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
8
|
Resverlogix Corp.
|
Aug 23, 2022 09:06AM
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
9
|
Resverlogix Corp.
|
Aug 17, 2022 12:27AM
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:55PM
|
Re: Hepalink
|
1
|
Resverlogix Corp.
|
Jun 13, 2022 01:50PM
|
Re: Hepalink
|
4
|
Resverlogix Corp.
|
Jun 13, 2022 12:57PM
|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 24, 2022 08:37PM
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 14, 2022 08:28PM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 14, 2022 07:48PM
|